Post by
Canadian_101 on Mar 11, 2020 10:00am
Meeting with FDA to Discuss Results
Jan D’Alvise, president and CEO of Acasti Pharma, commented, “We have completed the clinical site and central lab audits of the TRILOGY 1 data, including additional post-hoc analyses. As a result, I am pleased to report that we now expect to submit our FDA meeting request by the end of March. We look forward to reporting further developments, including an update on a meeting date as soon as it has been set.”
Comment by
Rosmorduc on Mar 11, 2020 10:53am
Yup, VERY positive. The FDA meeting would not be requested if they didn't complete their investigation with 100% confidence and satisfaction. As simple as that. Read between the lines. We're sitting on rocketfuel at these prices. When ignition happens, ohhhh baby!
Comment by
EternalPonzi on Mar 11, 2020 11:40am
Easy. Don't get too excited. Remember the chickens...
Comment by
Rosmorduc on Mar 11, 2020 3:07pm
Great news nevertheless. Everything on my screen is in the red today except for ACST. The company believes in its product and results to be applying and getting these patents or else they wouldn't be putting these news releases out just to make noise. Bigger news coming shortly.
Comment by
postie1 on Mar 11, 2020 3:49pm
Does anyone know who has the buy orders on the TSX for 290,500 shares at .51? Seems like somebody liked the news or is it a false bid.
Comment by
Rosmorduc on Mar 11, 2020 4:52pm
Likely the same people who sold at 2$+ now want back in. That's a large chunck.
Comment by
Canadian_101 on Mar 11, 2020 4:26pm
How's that SEC complaint going brother, they get back to ya yet, just wondering?
Comment by
EternalPonzi on Mar 12, 2020 6:08am
Negative. Don't expect anytime soon. Much bigger issues pending.
Comment by
jyuuto32 on Mar 15, 2020 2:40am
This post has been removed in accordance with Community Policy